본문으로 바로가기
Product Thumnail Image
Product Thumnail Image
Exibition

PBCheck COVID-19 IgG/IgM rapid chromatographic immunoassay

Negotiable / | Min Order Quantity Unit

Required Quantity

Place of Origin
South Korea
Payment Terms
Negotiable
Production method
Negotiable
Shipping / Lead Time
Negotiable / Negotiable
Keyword
antibody , rapid , sars , covid
Category
Examination & Testing Instrument , Monitoring & Diagnostic Equipment

1 Precision Bio Co., Ltd.

Supplier Activity

tradeKorea provides seller activity to buyers through seller evaluation and measurement according to each item.

Country South Korea South Korea

DUNS

PRODUCT DESCRIPTION
COMPANY INFORMATION
Product name PBCheck COVID-19 IgG/IgM rapid chromatographic immunoassay Certification CE
category Examination & Testing Instrument
Monitoring & Diagnostic Equipment
Ingredients -
Keyword antibody , rapid , sars , covid Unit Size -
Brand name - Unit Weigh -
origin South Korea Stock -
Supply type - HS code -
Product Information

PBCheck COVID-19 IgG/IgM is a rapid immunoassay for the qualitative detection of human IgG/IgM antibodies to SARS-CoV-2

in human whole blood, plasma and serum sample. The PBCheck  COVID-19 IgG/IgM Antibody Test is intended for use as an aid in identifying

individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

 

 

Features

 

• Quick and Easy to use

• Fast results in 10 minutes

• No equipment required

• Multiple sample type

 

 

Application

 

Serology testing for COVID-19 can be used to identify whether people were previously infected by SARS-CoV-2 even if they haven’t shown

symptoms. This is important to determine, because the RT-PCR tests now being used to diagnose the coronavirus can detect the presence

of the viral material during infection, but it doesn’t indicate if the person was previously infected and subsequently recovered.

 

• Identify asymptomatic patients

• Help to verify quarantine release

• Rapid screening of suspected case

• Epidemiological tracing

 

 

 

Clinical performance

 

 

PBCheckCOVID-19

IgG/IgM Antibody Test

Comparator / RT-PCR

Total

Positive

Negative

Positive

IgM+/IgG+

35

0

35

IgM+/IgG-

1

2

3

IgM*/IgG+

16

0

16

Negative

IgM-/IgG-

3

98

101

Total

55

100

155

Positive Percent Agreement (PPA)= 52/55 (94.55%), 95% CI: 85.15% to 98.13%

Negative Percent Agreement (NPA)= 98/100 (98.00%), 95% CI: 93.00% to 99.45%

 

 

Test procedure

 

 

Interpretation of results

 

 

·IgM only positive: Appearance of pinkish red colored bands at the control line and

the IgM test line indicate that the SARS-CoV-2 IgM antibody was detected.

 

· IgG only positive: Appearance of pinkish red colored bands at the control line and

the IgG test line indicate that the SARS-CoV-2 IgG antibody was detected.

 

· IgM and IgG positive: Appearance of pinkish red colored bands at the control line,

the IgG test line and the IgM test line indicate that the SARS-CoV-2 IgG and IgM antibodies are detected.

 

· Invalid: If no colored line appears in the control region (C), the test results is invalid.

The test result is inconclusive, and assay should be repeated with a new test cassette.

 

 

Product Specification

 

Sample volume

10μL Whole Blood

5μLSerum, Plasma

Measuring time

10 min

Pack size

20ea/box

Shelf life

12 months

Storage conditionRoom Temperature (2-30℃)

 

 

B2B Trade
Price (FOB) Negotiable transportation -
MOQ Negotiable Leadtime Negotiable
Payment Options Negotiable Shipping time Negotiable
Company

Precision Bio Co., Ltd.

Country South Korea South Korea

Supplier Activity

President
KIM HAN SIN
Address
306 Techno 2 ro, Yuseong-gu, Daejeon, Korea
Product Category
Examination & Testing Instrument,Monitoring & Diagnostic Equipment,Medical Test Kit,Other Examination & Testing Instrumnet,Other Monitoring & Diagnostic Equipment
Year Established
2015
Company introduction

 

Verified Certificate

  • CE

Other Products viewed with This Product